COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia

COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia

Blog Article

Background: This study explored vaccination hesitancy, diabetes-specific COVID-19 vaccination concerns, and whether they predicted vaccination uptake in people with diabetes.Methods: Quantitative, cross-sectional, and predictive approaches were used.An online survey was conducted with people with product diabetes attending four Australian health services, using convenience sampling (n = 842).

The survey data collected included clinico-demographic characteristics, COVID-19 vaccine hesitancy, and attitudes around COVID-19 vaccine confidence and complacency.Clinico-demographic characteristics that predicted vaccination status, vaccine hesitancy, and vaccine-related attitudes were identified using regression analyses.Results: Most participants received at least one COVID-19 vaccine dose.

Younger age and type 1 diabetes were associated with lower vaccination status, and they were partially mediated through higher vaccine hesitancy.Younger age and English as a dominant language were associated with higher negative attitudes towards speed of vaccine development.Conclusions: Despite an overall high vaccination rate, general and diabetes-specific COVID-19 vaccine concerns are a barrier to uptake for some people with diabetes, particularly in those who click here are younger or have type 1 diabetes.

A detailed understanding of concerns for particular subgroups can help tailor information to increase vaccine acceptance, particularly in the context of requiring booster doses.